Celiac Disease Treatment Options, Compared

Celiac disease has no cure, but symptoms can be managed with a strict gluten-free diet, medication, and an effective treatment plan. For people managing this lifelong autoimmune condition, understanding the available approaches—and how they differ—can make a significant difference in daily life and long-term health outcomes. The treatment landscape for celiac disease has expanded in recent years, moving beyond diet alone to include nutritional support and promising emerging therapies.

If you have been diagnosed with celiac disease or suspect you may have it, working with qualified healthcare professionals is essential. A gastroenterologist and registered dietitian can help you evaluate which approach or combination of approaches works best for your individual situation. This article compares the main categories of celiac disease treatment so you can understand your options.

The Gluten-Free Diet: The Cornerstone of Treatment

The most common and effective treatment of celiac disease is a change in diet. The only way to manage the symptoms of celiac disease is to eat a strict gluten-free diet, which lets your small intestine heal and stops future problems and inflammation. This means eliminating all foods and beverages containing wheat, barley, rye, and other gluten-containing grains.

As soon as you stop eating and drinking foods with gluten, your symptoms will begin to subside—from inflammation improving in a few short days and other symptoms healing slowly thereafter. For most people, strict adherence to a gluten-free diet provides substantial relief and allows the intestinal lining to recover.

However, the gluten-free diet comes with practical challenges. Food cross-contamination, nutritional imbalances, and persistent gastrointestinal symptoms are the main concerns related to a gluten-free diet. Despite careful attention, some individuals continue to experience symptoms, and maintaining this dietary approach requires ongoing vigilance and education.

Addressing Nutritional Gaps

Gluten-free diets are often low in fiber, iron, and calcium. Additionally, micronutrient deficiencies in particular iron, folic acid, vitamins B6 and B12, vitamin D, copper, and zinc are common in celiac patients. Because eliminating gluten-containing grains can mean losing important sources of these nutrients, supplementation often becomes necessary.

A gluten-free multivitamin/mineral supplement appropriate for your gender, age, diet and blood test results is a standard recommendation. After an initial blood test to determine a person's deficiencies, supplementation may be needed if patients are not getting enough micronutrients from their normal diet. Your healthcare provider can recommend the specific supplements that address your individual needs.

Emerging Enzyme-Based Therapies

Intraluminal interventions include gluten-degrading enzymes and gluten-sequestering agents. These represent a new category of treatments designed to work alongside the gluten-free diet. Enzymes such as ALV003 are designed to break down gluten peptides in the digestive tract before they can trigger an immune response.

One enzyme candidate, latiglutenase, has shown promise in clinical research. The technology has been extensively studied in phase 1 and phase 2 clinical trials where it has been shown to lessen gluten-induced intestinal mucosal injury as well as improve symptoms. It is designed to be taken as a supplement to a gluten-free diet, rather than a replacement for it.

It is important to note that digestive enzyme supplements are ineffective in degrading problematic gluten, and experts have warned patients not to use digestive enzyme supplements on the market. Prescription enzyme therapies under development are different from over-the-counter products.

Intestinal Barrier Modulators

Drugs can enhance the strength of the intestinal barrier or prevent its disruption, thereby reducing the luminal passage of immunogenic gluten peptides. Larazotide acetate is prototypical in this category: it is designed to stabilize the tight junctions between intestinal epithelial cells, thereby decreasing gluten peptide leakage into the lamina propria.

These therapies target a different part of the disease process than enzyme treatments. Rather than breaking down gluten, they work to strengthen the intestinal walls and prevent gluten peptides from entering the immune system in the first place. Larazotide acetate has been studied extensively in Phase 2 and 3 clinical trials, and while its safety and preliminary efficacy are promising, regulatory agencies are still evaluating its endpoints.

Immune-Modulating Approaches

Other approaches target tissue transglutaminase 2, induce antigen-specific immune tolerance, or modulate cytokine-driven inflammation, with particular emphasis on interleukin-15 signaling. These therapies work at a deeper level, addressing the underlying immune dysfunction that causes celiac disease.

Rather than preventing gluten from reaching the intestine or breaking it down, these therapies aim to retrain the immune system or reduce the inflammatory response it triggers. Such approaches could potentially address the root cause of the disease, though research in this area is ongoing and none of the new drugs have achieved full regulatory approval as standalone treatments for celiac disease.

Probiotics and Microbiota Support

Pivotal studies on the supplementation of a gluten-free diet with probiotics, such as Bifidobacterium and Lactobacilli, reported a potential to restore gut microbiota composition and to pre-digest gluten in the intestinal lumen, reducing the inflammation associated with gluten intake, the intestinal permeability, and the cytokine and antibody production.

Research has found that probiotics may offer additional benefits alongside strict diet adherence. However, evidence is still developing, and probiotics are generally considered a supportive therapy rather than a primary treatment. Despite rigid compliance to a gluten-free diet, patients struggle in achieving a full restoring of the gut microbiota, which plays a role in the nutritive compounds processing and absorption.

Treatment Comparison Table

Managing Treatment-Resistant Symptoms

Although strict adherence to a gluten-free diet remains the cornerstone of treatment, up to 30–40% of patients experience persistent symptoms and/or ongoing mucosal injury despite reported compliance. In these cases, combining approaches may help. In certain cases, a change in diet will not be enough to resolve serious symptoms such as severe inflammation. Medication, including steroids, may be a valid option based on diagnosis and symptom severity.

For individuals with this experience, working closely with a gastroenterologist to investigate the cause of ongoing symptoms is important. Possible explanations include accidental gluten exposure, additional food intolerances, or a condition requiring additional medical management.

Key Takeaways: Choosing Your Treatment Path 💡

• 🍽️ The gluten-free diet remains the foundation of all celiac disease treatment; all other approaches are designed to support or complement it, not replace it.
• Nutritional supplementation is often necessary to correct deficiencies caused by eliminating gluten-containing grains; testing and personalized recommendations are key.
• Emerging therapies are still in development and not yet approved for independent use, though enzyme and barrier-modulating drugs show promise in clinical trials.
• Combining approaches may help when symptoms persist despite strict diet adherence; discuss options with your healthcare team.
• Over-the-counter digestive enzyme supplements are not effective for gluten degradation; prescription-based enzyme therapies under development work differently.
• Individual response varies; what works best depends on your specific symptoms, nutritional status, and compliance with diet.

Celiac disease management is becoming more personalized as research advances. The considerable practical limitations and psychosocial burden associated with long-term dietary restriction have stimulated increasing interest in adjunctive and alternative therapeutic strategies aimed at improving disease control and quality of life. Work with your healthcare team to develop a comprehensive plan that addresses both your nutritional needs and symptom management. Regular monitoring and open communication about your progress can help you adjust your approach as needed.